Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FgoKDGMxCUARhvPgaUvm4yJ_E5ew.uncropped.jpg&w=3840&q=75)
Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 7 locations, replacing the previous version v2.9.7.SummaryDifference0.2%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study on Immunotherapy followed by EGFR Inhibitor in Locally Advanced or Metastatic Squamous Cell Cancer of the Skin. The update likely includes new information or modifications to the study protocol or details.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the webpage content related to the study on Immunotherapy followed by EGFR Inhibitor in Locally Advanced or Metastatic Squamous Cell Cancer of the Skin, focusing on the combination treatment strategy with pembrolizumab and cetuximab to tackle primary and secondary resistance.SummaryDifference0.0%
- Check32 days agoChange DetectedThe value 'Show more Show more Show more' has been updated to 'Show less Show less'. Additionally, the revision has changed to v2.9.1.SummaryDifference15%
Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.